Nuclera (Series C)
Funding Details
Awarder
Inbox
Date Award
January 15, 2026
Vertical
Biotechnology
Funding Amount
$12,000,000
Company Info
Founders
Michael Chen
Market
Protein Science
Location
Billerica, MA, USA
Coinvestors
British Business Bank, Elevage Medical Technologies, GK Goh, Jonathan Milner
Company Description

Nuclera exists to remove uncertainty from protein science. As the pioneer of multiplex protein screening, the company helps researchers start with clarity, so ideas move faster to result. Nuclera believes access to your protein should be a certainty, not a gamble.

Links